Follow us on:
Breaking News
May 18, 2026
Breaking News
Breaking News
Allos _ENL_051826_650x90
Tomorrow at Contract Pharma
Marken_Webinar_051926_ThisMonth@

FDA Approves First Simponi Biosimilars in U.S.

 
FDA Approves First Simponi Biosimilars in U.S.

Accord BioPharma will be responsible for commercializing IMMGOLIS and IMMGOLIS INTRI in the U.S.
Read More >>

Headlines

Breaking News
Collaborations & Alliances

Parabilis Medicines, Regeneron Partner to Advance Novel Antibody-Helicon Conjugates

The multi-target collaboration combines Parabilis’s novel Helicon peptide platform with Regeneron’s antibody capabilities

SPONSOR

Reduce risk and optimize consistent biomanufacturing growth

Choosing the right cell culture media supplier is critical to quality, consistency, and reliable supply. Learn five key factors to reduce risk and scale.

Breaking News
Collaborations & Alliances

Piramal Pharma Solutions, Botanix Partner to Support Drug Substance Development

PPS to leverage its North American drug substance facilities to support patient access to Sofdra.

Breaking News
Trials & Filings

Valar Labs Gets FDA Breakthrough Device Nod for Vesta Bladder Cancer Risk Test

Vesta Bladder Risk Stratify Dx becomes the first AI-powered digital pathology prognostic test in bladder cancer to receive the designation.

SPONSOR

Bend Bioscience’s Expanded Vision for Complex Drug Delivery

CEO Owen Murray on driving innovation with high science and high service.

CP-Stream_ContentHub_650x250

Breaking News
Collaborations & Alliances

Telix to Explore PSMA-PET Imaging in Collaborations with EDAP and Profound

Aim to advance the integration of molecular imaging into the evolving prostate cancer treatment landscape.

SPONSOR

[VIDEO] The Importance of High-Purity DMSO for Today’s Pharmaceuticals

Nigel Langley of gChem discusses the advantages of its high-purity Dimethyl sulfoxide in pharmaceutical applications.

Featured Resources

Solution Content Center SPOTLIGHT

Adare Pharma Solutions

Adare Pharma Solutions is a global technology-driven CDMO providing end-to-end integrated services, from product development through commercial manufacturing and packaging, with small molecule expertise focusing on oral dosage forms. Adare’s specialized technology platforms provide taste masking, customized release, multiparticulate systems, and patient-centric dosing solutions. With a proven history in drug delivery, Adare’s facilities in the US and Europe have developed and manufactured more than sixty-five products sold by customers worldwide.

 

Solution Center SPOTLIGHT

Formulated Solutions

Formulated Solutions is a leading North American CDMO, specializing in Rx, OTC, and medical devices. With 600+ experts and 800,000 sq. ft. across two sites, we develop, manufacture, and package topicals, nasal sprays, liquids, and aerosols. Our proprietary technologies power brands in 40+ countries, delivering innovation at scale since 1999.